Shafir I, Feng W, Shoshan-Barmatz V
Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Eur J Biochem. 1998 May 1;253(3):627-36. doi: 10.1046/j.1432-1327.1998.2530627.x.
In a recent study [Shoshan-Barmatz, V., Orr, I., Weil, S., Meyer, H., Varsanyi, M. & Heilmeyer, L. M. G. (1996) FEBS Lett. 386, 205-210] we have demonstrated the presence of the voltage-dependent anion channel (VDAC) in skeletal muscle sarcoplasmic reticulum (SR) as supported here by co-localization of VDAC and (Ca2+ + Mg2+)ATPase in the SR using double-immunogold labeling. The interaction of the carboxyl-modifying reagent dicyclohexylcarbodiimide with the SR-VDAC is characterized by labeling with [14C]dicyclohexylcarbodiimide and by dicyclohexylcarbodiimide modification of the reconstituted-purified VDAC channel activity. In both SR and mitochondrial membranes, [14C]dicyclohexylcarbodiimide most specifically labeled a 35-kDa protein, identified as VDAC by specific anti-VDAC Ig. Labeling of the SR-VDAC was about twofold higher than that of the mitochondrial VDAC, which could result either form higher labeling of the SR protein or from relatively higher amounts of VDAC/mg total protein in the SR membranes. [14C]Dicyclohexylcarbodiimide labeling of the SR, but not the mitochondrial VDAC, was biphasic with respect to time and concentration of [14C]dicyclohexylcarbodiimide. Partial digestion of [14C]dicyclohexylcarbodiimide-labeled SR-VDAC with chymotrypsin yielded five proteolytic fragments which were recognized by the anti-VDAC Ig, and the dicyclohexylcarbodiimide-binding site was localized in the 19-kDa fragment. VDAC was purified from SR and mitochondrial membranes by spermine-agarose column. The interaction of dicyclohexylcarbodiimide with functional carboxyl residue(s) in the purified VDAC is demonstrated by recording its channel activity, following its reconstitution into planar lipid bilayer (PLB). Dicyclohexylcarbodiimide inhibited the channel activity in a voltage-dependent manner, requiring incubation with dicyclohexylcarbodiimide at high (negative or positive) potentials. Dicyclohexylcarbodiimide slowed down the transition from the high-conducting to a long-lived low-conducting states of the channel (approximately 20% of its maximal conductance), by stabilizing the intermediate states. Similar results were also obtained with purified-reconstituted mitochondrial VDAC. Hydrophilic carboxyl reagents [[1-ethyl-3-(3-dimethylamino)propyl] carbodiimide, N-ethyl-phenylisoxazolium-3'-sulfonate] neither modified the channel activity nor prevented [14C]dicyclohexylcarbodiimide labeling. These results indicate that dicyclohexylcarbodiimide interacts with a carboxyl group located in a hydrophobic region of the protein which is involved in the channel gating.
在最近的一项研究中[肖尚 - 巴尔马茨,V.,奥尔,I.,韦尔,S.,迈耶,H.,瓦尔萨尼,M. & 海尔迈尔,L. M. G.(1996年)《欧洲生物化学学会联合会快报》386卷,205 - 210页],我们已经证实在骨骼肌肌浆网(SR)中存在电压依赖性阴离子通道(VDAC),此处通过使用双免疫金标记法显示VDAC与SR中的(Ca2 + + Mg2 +)ATP酶共定位来支持这一结论。羧基修饰试剂二环己基碳二亚胺与SR - VDAC的相互作用通过用[14C]二环己基碳二亚胺标记以及对重组纯化的VDAC通道活性进行二环己基碳二亚胺修饰来表征。在SR膜和线粒体膜中,[14C]二环己基碳二亚胺最特异性地标记了一种35 kDa的蛋白质,通过特异性抗VDAC Ig鉴定为VDAC。SR - VDAC的标记比线粒体VDAC的标记高约两倍,这可能是由于SR蛋白的标记更高,或者是由于SR膜中VDAC / mg总蛋白的含量相对更高。SR的[14C]二环己基碳二亚胺标记,但线粒体VDAC的标记并非如此,在[14C]二环己基碳二亚胺的时间和浓度方面是双相的。用胰凝乳蛋白酶对[14C]二环己基碳二亚胺标记的SR - VDAC进行部分消化产生了五个蛋白水解片段,这些片段被抗VDAC Ig识别,并且二环己基碳二亚胺结合位点位于19 kDa片段中。通过精胺 - 琼脂糖柱从SR膜和线粒体膜中纯化VDAC。通过记录其通道活性,在将其重组到平面脂质双层(PLB)中之后,证明了二环己基碳二亚胺与纯化的VDAC中的功能性羧基残基相互作用。二环己基碳二亚胺以电压依赖性方式抑制通道活性,需要在高(负或正)电位下与二环己基碳二亚胺孵育。二环己基碳二亚胺通过稳定中间状态减缓了通道从高传导状态到长寿命低传导状态的转变(约为其最大电导率的20%)。用纯化重组的线粒体VDAC也获得了类似的结果。亲水性羧基试剂[[1 - 乙基 - 3 - (3 - 二甲基氨基)丙基]碳二亚胺,N - 乙基 - 苯基异恶唑鎓 - 3'-磺酸盐]既不修饰通道活性也不阻止[14C]二环己基碳二亚胺标记。这些结果表明,二环己基碳二亚胺与位于蛋白质疏水区域中参与通道门控的羧基相互作用。